Savion M, Segenreich E, Kahan E, Servadio C
Urology. 1987 May;29(5):510-2. doi: 10.1016/0090-4295(87)90040-9.
A group of impotent patients previously treated with Strychiomel was evaluated. Strychiomel is a compound of three drugs, yohimbine, thioridazine (Mellaril), and strychnine sulfate, each of which has a specific effect. The results suggest that the compound drug may be beneficial in the majority of patients (66.7%) when impotence occurs without hormonal or severe vascular or psychologic problems. Other factors such as age or presence of other simultaneous diseases do not appear to be significant when treatment with this multiaction drug (Strychiomel) is utilized.
对一组先前接受过士的宁美乐治疗的阳痿患者进行了评估。士的宁美乐是三种药物的复合物，即育亨宾、硫利达嗪（甲硫达嗪）和硫酸士的宁，每种药物都有特定的作用。结果表明，当阳痿发生且不存在激素、严重血管或心理问题时，复合药物可能对大多数患者（66.7%）有益。在使用这种多作用药物（士的宁美乐）进行治疗时，年龄或其他并发疾病等其他因素似乎并不重要。
